THE Food and Drug Administration (FDA) gave assurances that the supply of drugs used to treat symptoms of Covid-19 remains stable as it allowed a Chinese firm to supply the country with tocilizumab, an anti-inflammatory drug.
FDA Director-General Rolando Enrique Domingo said it has approved the tocilizumab made by Livzon Mabpharm.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.